Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.58.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.8.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDNNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.8.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.54.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.30.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.55.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19812.6China
BA.2.3.6NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-19797.4US
B.1.599NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-19788.4Germany
B.1.599NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19777.6South Korea
KB.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19777.6South Korea
JN.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
GK.1.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
C.36.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XBB.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
C.36.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.521NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
KF.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
FL.15.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.1.425NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used